Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals.

J Pers Med · 2023 · PMC10455277 · PMID 37623439

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, in our previous study performed in a Turkish population of HCV patients, it was shown that the expression of this miRNA in HCV patients who achieved an SVR after treatment with ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin was decreased, even if the difference did not reach statistical significance [ 32 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.